Detailed financial statements for None (SRTS): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year with up to 20 years of history.
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy.
Analysis Summary
None reported revenue of $27.5M in the most recent fiscal year, growing at a 5-year CAGR of 23.5%.
Balance sheet quality for SRTS: current ratio of 9.7, net cash position of $21.4M. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Revenue | $14.8M | $20.6M | $26.4M | $27.3M | $9.6M | $27.0M | $44.5M | $24.4M | $41.8M | $27.5M |
| Cost of Revenue | $5.0M | $6.8M | $9.5M | $9.7M | $4.3M | $10.1M | $14.9M | $10.3M | $17.4M | $15.6M |
| Gross Profit | $9.8M | $13.8M | $16.9M | $17.6M | $5.2M | $17.0M | $29.6M | $14.1M | $24.4M | $11.9M |
| Research & Development | $1.8M | $5.5M | $6.3M | $6.4M | $4.2M | $3.4M | $3.5M | $3.7M | $4.2M | $7.8M |
| Selling, General & Admin | $8.4M | $12.0M | $12.7M | $13.1M | $9.3M | $9.4M | $11.3M | $10.8M | $12.1M | $14.4M |
| Operating Expenses | $10.2M | $17.5M | $18.9M | $19.5M | $13.5M | $12.9M | $14.8M | $14.4M | $16.3M | $22.2M |
| Operating Income | -$363119 | -$3.7M | -$2.0M | -$2.0M | -$8.2M | $4.1M | $14.8M | -$382000 | $8.1M | -$10.3M |
| EBITDA | $13002 | -$3.3M | -$1.2M | -$1.2M | -$6.1M | $4.7M | $28.5M | $1.1M | $9.5M | -$9.2M |
| Interest Expense | $21867 | $68881 | $156685 | 0 | $14000 | $1000 | $2000 | 0 | 0 | 0 |
| Pre-tax Income | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $28.0M | $652000 | $9.0M | -$9.6M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | $3.7M | $167000 | $2.4M | -$1.9M |
| Net Income | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $24.2M | $485000 | $6.6M | -$7.7M |
| EPS | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.47 | $0.03 | $0.41 | $-0.47 |
| EPS (Diluted) | $-0.03 | $-0.28 | $-0.14 | $-0.07 | $-0.42 | $0.25 | $1.46 | $0.03 | $0.41 | $-0.47 |
| Shares Outstanding (Diluted) | $12.0M | $13.2M | $14.1M | $16.2M | $16.4M | $16.5M | $16.6M | $16.3M | $16.4M | $16.3M |
Income Statement (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Revenue | $6.9M | $4.9M | $3.4M | $2.3M |
| Gross Profit | $2.7M | $1.9M | $991000 | $769000 |
| Operating Income | -$2.6M | -$3.1M | -$4.4M | -$3.2M |
| EBITDA | $621999 | -$2.9M | -$4.1M | -$3.1M |
| Net Income | -$943000 | -$3.2M | -$2.6M | -$8.7M |
| EPS | $-0.06 | $-0.19 | $-0.16 | $-0.53 |
| EPS (Diluted) | $-0.06 | $-0.19 | $-0.16 | $-0.53 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Cash & Equivalents | $5.0M | $10.1M | $12.5M | $8.1M | $14.9M | $14.5M | $25.5M | $23.1M | $22.1M | $22.1M |
| Short-term Investments | $6.5M | $1.1M | $2.9M | $7.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $3.1M | $5.0M | $13.1M | $14.0M | $3.8M | $12.1M | $17.3M | $10.6M | $19.7M | $6.0M |
| Inventory | $1.3M | $1.2M | $1.6M | $3.0M | $4.4M | $1.8M | $3.5M | $11.9M | $10.1M | $14.6M |
| Total Current Assets | $16.8M | $17.9M | $31.9M | $34.0M | $25.2M | $31.2M | $53.2M | $49.5M | $56.7M | $45.9M |
| Property, Plant & Equipment | $433408 | $394078 | $891029 | $2.5M | $2.4M | $774000 | $1.2M | $1.2M | $2.6M | $2.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $626509 | $530123 | $433737 | $337351 | $338000 | $146000 | $50000 | 0 | 0 | 0 |
| Total Assets | $18.9M | $18.8M | $33.3M | $36.9M | $28.0M | $32.2M | $56.7M | $53.7M | $62.2M | $53.0M |
| Accounts Payable | $2.8M | $4.1M | $5.2M | 0 | 0 | $4.1M | $5.5M | $2.8M | $4.8M | $3.3M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | $51000 | 0 | 0 | 0 | $262000 |
| Total Current Liabilities | $3.7M | $7.1M | $6.0M | $6.5M | $4.9M | $6.0M | $7.7M | $4.2M | $5.9M | $4.7M |
| Long-term Debt | 0 | $2.2M | 0 | 0 | $267000 | 0 | 0 | 0 | 0 | $209000 |
| Total Liabilities | $3.7M | $7.2M | $6.8M | $8.9M | $6.5M | $6.2M | $8.7M | $4.9M | $6.3M | $4.9M |
| Retained Earnings | -$7.8M | -$11.5M | -$13.5M | -$15.2M | -$22.1M | -$17.9M | $6.3M | $6.8M | $13.4M | $5.7M |
| Total Equity | $15.3M | $11.7M | $26.5M | $28.0M | $21.5M | $26.0M | $48.1M | $48.8M | $55.8M | $48.1M |
| Total Debt | 0 | $2.2M | 0 | $1.4M | $1.4M | $225000 | $1.0M | $783000 | $602000 | $680000 |
| Net Debt | -$11.5M | -$9.0M | -$15.4M | -$14.1M | -$13.5M | -$14.3M | -$24.5M | -$22.4M | -$21.5M | -$21.4M |
| Working Capital | $13.1M | $10.8M | $25.9M | $27.5M | $20.3M | $25.3M | $45.5M | $45.3M | $50.9M | $41.2M |
Balance Sheet (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Cash & Equivalents | $24.5M | $22.1M | $18.3M | $15.2M |
| Total Assets | $58.3M | $53.0M | $51.5M | $41.3M |
| Total Liabilities | $7.1M | $4.9M | $6.0M | $4.4M |
| Total Equity | $51.2M | $48.1M | $45.5M | $36.9M |
| Total Debt | $534000 | $680000 | $407000 | $343000 |
Cash Flow (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Net Income | -$346448 | -$3.7M | -$2.0M | -$1.7M | -$6.8M | $4.1M | $24.2M | $485000 | $6.6M | -$7.7M |
| Depreciation & Amortization | $337583 | $387917 | $658255 | $545717 | $721865 | $613000 | $509000 | $461000 | $432000 | $626000 |
| Stock-based Compensation | $726377 | $405896 | $982624 | $620925 | 0 | $415000 | $187000 | $328000 | $323000 | $295000 |
| Change in Working Capital | -$4.6M | -$568857 | -$8.3M | -$2.3M | $5.6M | -$6.1M | -$12.9M | -$3.6M | -$8.6M | $8.7M |
| Operating Cash Flow | -$851024 | -$3.1M | -$8.6M | -$2.1M | -$434180 | -$286000 | -$1.4M | -$2.1M | -$831000 | $528000 |
| Capital Expenditure | -$285998 | -$287594 | -$854834 | -$400588 | -$358540 | -$128000 | -$159000 | -$229000 | -$276000 | -$196000 |
| Acquisitions | $7.9M | 0 | $2.64B | 0 | 0 | $257000 | $15.0M | 0 | 0 | 0 |
| Stock Repurchased | 0 | -$289286 | 0 | 0 | 0 | -$15000 | -$3.0M | -$27000 | 0 | -$300000 |
| Dividends Paid | -$2.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -$1.1M | -$3.3M | -$9.4M | -$2.5M | -$792720 | -$414000 | -$1.6M | -$2.4M | -$1.1M | $332000 |
Cash Flow (Quarterly)
| Year | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Operating Cash Flow | $2.3M | -$2.2M | -$3.8M | -$3.1M |
| Capital Expenditure | -$4000 | -$158000 | -$3000 | $3000 |
| Free Cash Flow | $2.3M | -$2.4M | -$3.8M | -$3.1M |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Stock-based Compensation | $73000 | $76000 | $70000 | $70000 |
Growth & Margins (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Revenue Growth (YoY) | | +39.0% | +28.4% | +3.2% | -64.9% | +182.4% | +64.7% | -45.2% | +71.3% | -34.3% |
| Net Income Growth (YoY) | | -971.0% | +45.5% | +16.0% | -302.1% | +160.3% | +488.6% | -98.0% | +1270.5% | -216.1% |
| EPS Growth (YoY) | | -872.2% | +50.0% | +49.2% | -490.7% | +159.5% | +488.0% | -98.0% | +1275.8% | -214.6% |
| Shares Change (YoY) | | +10.0% | +6.6% | +15.0% | +1.2% | +0.4% | +0.7% | -2.1% | +0.6% | -0.2% |
| FCF Growth (YoY) | | -194.1% | -181.6% | +73.4% | +68.4% | +47.8% | -279.5% | -51.1% | +53.4% | +130.0% |
| Gross Margin | 66.5% | 67.0% | 64.0% | 64.4% | 54.8% | 62.8% | 66.5% | 57.6% | 58.4% | 43.2% |
| Operating Margin | -2.5% | -18.1% | -7.6% | -7.2% | -86.0% | 15.2% | 33.3% | -1.6% | 19.4% | -37.5% |
| EBITDA Margin | 0.1% | -15.8% | -4.6% | -4.2% | -63.7% | 17.5% | 64.0% | 4.6% | 22.6% | -33.6% |
| Net Margin | -2.3% | -18.0% | -7.7% | -6.2% | -71.4% | 15.2% | 54.4% | 2.0% | 15.9% | -28.1% |
| FCF Margin | -7.7% | -16.2% | -35.6% | -9.2% | -8.3% | -1.5% | -3.5% | -9.7% | -2.6% | 1.2% |
| Effective Tax Rate | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | 13.4% | 25.6% | 26.3% | 19.8% |
Per-Share Data (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF Per Share | $-0.09 | $-0.25 | $-0.67 | $-0.15 | $-0.05 | $-0.03 | $-0.09 | $-0.15 | $-0.07 | $0.02 |
| Dividends Per Share | $0.21 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | $12.0M | $13.2M | $14.1M | $16.2M | $16.4M | $16.5M | $16.5M | $16.3M | $16.3M | $16.3M |
Financial Health
| Piotroski F-Score | 3 |
| Altman Z-Score | 8.85 |
Key Ratios (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -182.29 | -18.43 | -52.93 | -49.79 | -9.19 | 28.88 | 5.05 | 79.19 | 16.88 | -8.47 |
| P/B | 4.13 | 5.85 | 3.95 | 2.05 | 2.95 | 4.57 | 2.54 | 0.79 | 2.02 | 1.35 |
| P/S | 4.26 | 3.32 | 3.96 | 2.11 | 6.62 | 4.40 | 2.75 | 1.57 | 2.70 | 2.36 |
| Gross Margin | 66.5% | 67.0% | 64.0% | 64.4% | 54.8% | 62.8% | 66.5% | 57.6% | 58.4% | 43.2% |
| Operating Margin | -2.5% | -18.1% | -7.6% | -7.2% | -86.0% | 15.2% | 33.3% | -1.6% | 19.4% | -37.5% |
| Net Margin | -2.3% | -18.0% | -7.7% | -6.2% | -71.4% | 15.2% | 54.4% | 2.0% | 15.9% | -28.1% |